🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 75901B107
- Market Cap
- Mid Cap
- IPO
- 9/16/2015 · $22.00/share
Business: REGENXBIO, Inc. is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy. The Company’s mission is to transform the lives of patients suffering from severe diseases with significant unmet medical needs by developing and commercializing in vivo gene therapy products based on the Company’s NAV Technology Platform.
Company Contact
- CEO
- Kenneth T. Mills
- CFO
- Mitchell Chan
- Headquarters
- 9712 Medical Center Drive, Suite 100, Rockville, MD 20850
- Phone
- 241-552-8181
- Investor Relations
- Elizabeth Broder, The Trout Group · 646-378-2945 · ebroder@troutgroup.com